Skip to main content
Clinical Trials/NCT03962218
NCT03962218
Completed
Not Applicable

Randomized Controlled Trial to Assess the Effectiveness of Aquatic Specific Physiotherapy in the Improvement of Balance and Gait.

University of Castilla-La Mancha1 site in 1 country50 target enrollmentJanuary 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spinal Cord Injuries
Sponsor
University of Castilla-La Mancha
Enrollment
50
Locations
1
Primary Endpoint
balance
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Purpose of the study: To analyse the effectiveness of aquatic physiotherapy on spinal cord injuries (LMi) in the improvement of balance and gait, in the inflammatory profile, and the impact on the quality of life.

Main objective: To analyse if there are differences in the recovery of the balance, in incomplete subacute spinal cord injuries, with lesion level T1-L5 and ASIA (American Spinal Injury Association) C and D .

Secondary objectives:

  1. functional gait
  2. To evaluate if the time from the injury to the start of the aquatic therapy influences the results on balance and functional gait.
  3. To study the effect of aquatic therapy on serum markers of systemic inflammation.
  4. Quality of life related to health. Design: Crossed, controlled and randomized clinical trial, with blind evaluation of the response variables.

Scope of the study: National Hospital of Paraplegics. Toledo (Spain). Population: Subjects with incomplete spinal cord injury ASIA C and D. n = 50 (25 in each arm randomly).

Intervention:

6 weeks of specific Aquatic Physiotherapy (3 times a week). Group 1 will perform aquatic physiotherapy at the time of entering the study, and group 2 will perform it 6 weeks later.

Outcomes: Static and dynamic balance (Berg test and Time Up and Go). Speed of the gait (test of 10 m.). Gait resistance (6 min. Test). Functional capacity of the gait (WISCI II). Biomechanical analysis (sensorial-dynamic, rhythmic and directional control, and gait test) by posturography. Questionnaires EuroQol-5Dimensions-5Level (EQ-5D-5L) and the Spanish Version of the Quality of Life Index (SV-QLI) in spinal cord injury (SCI).

Biomarkers of inflammation: 20 cytokines. Analysis of results: The main outcome measure will be the percentage of patients who have improved. Considering improvement when the difference between the groups is, at least, a 10% of their score in the Berg test between V0 and V1 (with their corresponding 95% confidence intervals). It will be adjusted for confounding and interaction factors with a multivariate analysis using logistic regression. All analyses will be performed according to the intention to treat principle.

Registry
clinicaltrials.gov
Start Date
January 1, 2020
End Date
November 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
University of Castilla-La Mancha
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects with incomplete spinal cord injury T1-L5 (ASIA C y D).
  • Traumatic and not traumatic injuries, with injury date of less than 8 months.
  • Able to maintain assisted standing up
  • Subjects signing the informed consent form

Exclusion Criteria

  • Subjects with progressive injuries.
  • heart or lung disease

Outcomes

Primary Outcomes

balance

Time Frame: 12 weeks

Berg test

Speed of the gait

Time Frame: 12 weeks

test of 10 m

Gait resistance

Time Frame: 12 weeks

6 Minutes Walk Test

Functional capacity of the gait

Time Frame: 12 weeks

Walking Index for spinal cord injury (WISCI II)

Secondary Outcomes

  • General quality of life related to Health(12 weeks)
  • Specific quality of life related to health in spinal cord injury(12 weeks)
  • Inflammatory cytokines analysis(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials